Remember that phase trial that went 40% over budget because CRO costs weren't properly allocated?
Our founders spent months interviewing CFOs from 50+ biotech companies to create something different for you: 10x CFO for Biotech and Pharma companies.
This isn't another generic finance guide. It's a playbook for finance leaders managing:
Multi-dimensional project allocation across trials and phases
Risk-adjusted NPV calculations that actually work
Clinical trial budgeting that accounts for CRO variability
Cash runway forecasting under multiple scenarios
GTN waterfalls and commercialization planning
Plus examples and success cases from companies navigating FDA approvals, Series B rounds, and everything in between.
